2019年冠状病毒病(COVID-19)
大流行
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
病毒学
传输(电信)
医学
医疗急救
疾病
爆发
传染病(医学专业)
电气工程
工程类
病理
摘要
Severe Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 110 million COVID 19 cases and 2.5 million deaths globally. Safe and effective vaccines are the most important tools to contain the ongoing Covid-19 pandemic. With unprecedented speed and efficiency, the worldwide endeavor is bearing fruit. A handful of vaccines have been authorized either as Emergency Use or Conditional Approval worldwide. Preliminary real-world data has indicated that these vaccines prevent Covid-19 illness, including severe disease and related death, as well as reduce transmission. This review discusses three major factors that contributed to the lightning speed of Covid-19 vaccine development and provides an overview of Phase 3 study results and preliminary real-world evidence. [Am J Transl Med 2021. 5 (1):1-12].
科研通智能强力驱动
Strongly Powered by AbleSci AI